Indo Us Bio-Tech Ltd - 541304 - Corporate Action-Board recommends Bonus Issue
Outcome of Board Meeting07-07-2023
07-07-2023
Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Meeting Held On Friday, July 7, 2023
Outcome of Board Meeting07-07-2023
Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for To Increase Authorised Share Capital Of The Company, To Recommend For The Issue Of Bonus Shares To The Existing Shareholders Of The Company, To Call The Extra Ordinary General Meeting For The Purpose Of Approval Of Above Agendas.
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2023 ,inter alia, to consider and approve (1) To increase Authorised Share Capital of the Company. (2) To recommend for the Issue of Bonus Shares to the existing Shareholders of the company. (3) To Call the Extra Ordinary General Meeting for the purpose of approval of above agendas. (4) Any other Matter with the permission of the Chair. Please take the same on your record and oblige. Thanking you.30-06-2023
Indo Us Bio-Tech Ltd - 541304 - Closure of Trading Window
This is to inform you that , pursunat to SEBI PIT Regulations read with BSE vide circular No. LIST/COMP/01/2029-2022 dated 2nd April, 2019, the trading window for dealing in the securities of the company will remain closed from Saturday, 1st July, 2023 till 48 hours after announcement / declaration of Unaudited Financial Results for the quarter ended on 30-06-2023. This is for your information and record. Thanking You!30-06-2023
Indo Us Bio-Tech Ltd - 541304 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Dear Sir(s), Pursuant to Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the Annual Secretarial Compliance Report for the financial year ended on 31st March, 2023, duly issued by Shri Amrish N. Gandhi, Practising Company Secretary. Please take the same on record. Thanking you30-05-2023
Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to the subject mentioned above we are submitting the Newspaper Advertisement relating to Audited quarterly & yearly Standalone Financial Results for the quarter & year ended on 31st March, 2023 published in Western times - English and Western times - Gujarati Newspaper to comply Regulation 47 of SEBI LODR Regulations. Kindly take it in your record. Thanking you,05-05-2023
Indo Us Bio-Tech Ltd - 541304 - Results-Financial Results For March 31, 2023
We are submitting the Revised Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We hereby enclose the following documents again. 1. The Statement of Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2023. 2. Auditors'' Report on Standalone Audited Financial Results. This File is also being made available on the website of the Company at www.indousagriseeds.com. Please take the same on your records. Thanking you,03-05-2023
Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On 3Rd May, 2023 And Submission Of Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2023.
With reference to above, we hereby inform that meeting of Board of Directors of the Company held today (i.e., 03/05/2023), in which Board has approved and adopted the standalone Audited Financial Results of the Company for the Quarter and year ended 31st March, 2023. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following: 1. Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2023. 2. Auditors'' Report on Standalone Audited Financial Results. These are also being made available on the website of the Company at www.indousagriseeds.com. The meeting of Board of Directors commenced at 03.00 p.m and concluded at 04.15 p.m. Please take the same on your records. Thanking you03-05-2023
Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2023 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023. Further please be informed that, pursuant to "Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons" of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time-and as per our earlier submission vide letter dated March 31, 2023, the trading window of the Company has been closed for all Designated Persons and their immediate relatives with effect from April 01, 2023 and would remain closed until 48 hours after the announcement of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023 to the Stock Exchange. Kindly take the same on your record. Thanking you,26-04-2023
Indo Us Bio-Tech Ltd - 541304 - Submission Of Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended On 31.03.2023
With reference to the subject captioned above please find enclosed herewith the Certificate fromPracticing Company Secretary under Regulation 40(9) of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 for the year ended on 31st March, 2023. We request you to kindly take on record the above said certificate. Thanking You,20-04-2023